HYBRID EVENT: Join us in person in Barcelona, Spain or attend virtually from anywhere.

10th Edition of World Congress on Infectious Diseases

June 25-27, 2026 | Barcelona, Spain

June 25 -27, 2026 | Barcelona, Spain
Infection 2026

Genomic surveillance-guided adaptive allocation significantly reduces projected malaria incidence under artemisinin resistance

Speaker at Infection Conferences - Jenna Shoman
Harvard University, United States
Title : Genomic surveillance-guided adaptive allocation significantly reduces projected malaria incidence under artemisinin resistance

Abstract:

Background: Emerging artemisinin resistance and escalating insecticide resistance threaten recent gains in malaria control across sub-Saharan Africa. Despite this growing heterogeneity in parasite genetics and transmission intensity, intervention strategies are frequently deployed using uniform national approaches. We hypothesized that integrating parasite genomic surveillance with spatially resolved transmission modeling could identify high-impact, region-specific allocation strategies that outperform standard uniform deployment.

Methods: Publicly available Plasmodium falciparum genomic datasets (n > 12,000 isolates) were integrated with WHO malaria incidence estimates across 15 high-burden countries. Resistance-associated variants, including kelch13 and additional validated loci, were mapped using geospatial clustering and hotspot detection to identify regions of elevated resistance risk. These genomic risk surfaces were incorporated into a compartmental transmission model parameterized with vector dynamics, intervention coverage (ITNs, ACTs, IRS), treatment-seeking behavior, and health-system access. Standard national strategies were compared with
genomic-guided adaptive allocation over a 10-year projection horizon. Probabilistic sensitivity analyses were conducted to evaluate robustness across plausible resistance growth and coverage scenarios.

Results: High-resistance clusters were associated with a modeled 18–27% reduction in ACT parasite clearance probability (p < 0.01) and increased rebound risk under uniform allocation. Genomic-guided adaptive deployment reduced projected malaria incidence by 21.4% (95% CI: 17.8–24.9%) compared with standard strategies and improved cost-effectiveness by 14% in DALYs averted per dollar spent. Benefits persisted across sensitivity analyses under realistic operational constraints.

Conclusions: Genomic surveillance–guided intervention allocation substantially improves projected malaria control outcomes relative to uniform national strategies. Integrating parasite genomics into malaria elimination programs provides a scalable precision-public-health framework capable of mitigating resistance-driven resurgence and accelerating durable elimination efforts.

Biography:

Jenna Shoman is a sophomore at Harvard University concentrating in Human Evolutionary Biology with a secondary in Global Health and Health Policy. Her academic interests focus on molecular disease mechanisms and precision public health strategies to combat global infectious and noncommunicable diseases. She has prior faculty-mentored research experience in cancer progression and cellular plasticity, with strengths in quantitative data analysis. She is particularly interested in integrating genomic science with health systems implementation to address complex global health challenges such as infectious disease resistance.

Watsapp